LPL Financial’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.99M Sell
26,551
-5,262
-17% -$1.01M ﹤0.01% 2625
2025
Q4
$6.02M Buy
31,813
+12,351
+63% +$2.29M ﹤0.01% 2378
2025
Q3
$3.22M Sell
19,462
-2,833
-13% -$462K ﹤0.01% 2870
2025
Q2
$3.42M Sell
22,295
-1,880
-8% -$280K ﹤0.01% 2624
2025
Q1
$3.8M Sell
24,175
-572
-2% -$92.8K ﹤0.01% 2385
2024
Q4
$3.88M Sell
24,747
-1,527
-6% -$257K ﹤0.01% 2275
2024
Q3
$4.66M Buy
26,274
+878
+3% +$156K ﹤0.01% 2056
2024
Q2
$4.28M Buy
25,396
+994
+4% +$163K ﹤0.01% 1988
2024
Q1
$4.06M Buy
24,402
+3,517
+17% +$582K ﹤0.01% 1945
2023
Q4
$3.45M Sell
20,885
-22,184
-52% -$3.41M ﹤0.01% 1953
2023
Q3
$6.71M Sell
43,069
-2,916
-6% -$466K ﹤0.01% 1423
2023
Q2
$7.18M Sell
45,985
-2,174
-5% -$347K 0.01% 1354
2023
Q1
$7.81M Sell
48,159
-1,284
-3% -$208K 0.01% 1239
2022
Q4
$7.9M Buy
49,443
+16,703
+51% +$2.65M 0.01% 1171
2022
Q3
$4.61M Sell
32,740
-9,985
-23% -$1.51M ﹤0.01% 1437
2022
Q2
$6.23M Sell
42,725
-1,764
-4% -$263K 0.01% 1241
2022
Q1
$7.21M Buy
44,489
+5,503
+14% +$891K 0.01% 1203
2021
Q4
$7.38M Buy
38,986
+5,593
+17% +$1.08M 0.01% 1201
2021
Q3
$6.75M Buy
33,393
+11,166
+50% +$2.34M 0.01% 1190
2021
Q2
$4.48M Buy
22,227
+1,266
+6% +$236K ﹤0.01% 1420
2021
Q1
$3.68M Buy
20,961
+742
+4% +$134K ﹤0.01% 1424
2020
Q4
$3.43M Sell
20,219
-2,472
-11% -$407K ﹤0.01% 1335
2020
Q3
$3.68M Sell
22,691
-8,453
-27% -$1.37M 0.01% 1111
2020
Q2
$5.07M Buy
31,144
+13,520
+77% +$2.05M 0.01% 872
2020
Q1
$2.26M Buy
17,624
+4,797
+37% +$646K ﹤0.01% 1120
2019
Q4
$1.79M Buy
12,827
+2,444
+24% +$321K ﹤0.01% 1431
2019
Q3
$1.23M Sell
10,383
-446
-4% -$55.5K ﹤0.01% 1589
2019
Q2
$1.4M Sell
10,829
-1,184
-10% -$146K ﹤0.01% 1483
2019
Q1
$1.54M Sell
12,013
-590
-5% -$74.5K ﹤0.01% 1345
2018
Q4
$1.4M Buy
12,603
+796
+7% +$96.2K ﹤0.01% 1289
2018
Q3
$1.61M Buy
11,807
+608
+5% +$79.1K ﹤0.01% 1330
2018
Q2
$1.34M Buy
11,199
+284
+3% +$33.5K ﹤0.01% 1420
2018
Q1
$1.31M Sell
10,915
-1,810
-14% -$227K ﹤0.01% 1404
2017
Q4
$1.58M Sell
12,725
-1,202
-9% -$154K ﹤0.01% 1222
2017
Q3
$1.87M Sell
13,927
-2,395
-15% -$312K 0.01% 1034
2017
Q2
$2.05M Sell
16,322
-1,962
-11% -$237K 0.01% 923
2017
Q1
$2.16M Sell
18,284
-4,481
-20% -$524K 0.01% 788
2016
Q4
$2.5M Sell
22,765
-666
-3% -$72.4K 0.02% 685
2016
Q3
$2.68M Sell
23,431
-1,307
-5% -$149K 0.03% 625
2016
Q2
$2.62M Sell
24,738
-33,847
-58% -$3.61M 0.02% 625
2016
Q1
$6.25M Sell
58,585
-8,988
-13% -$937K 0.02% 613
2015
Q4
$8.36M Buy
67,573
+32,030
+90% +$3.92M 0.02% 505
2015
Q3
$4.19M Sell
35,543
-11,375
-24% -$1.51M 0.02% 524
2015
Q2
$6.37M Sell
46,918
-10,991
-19% -$1.46M 0.03% 424
2015
Q1
$7.41M Buy
57,909
+21,838
+61% +$2.74M 0.04% 380
2014
Q4
$4.16M Buy
36,071
+5,256
+17% +$592K 0.02% 559
2014
Q3
$3.21M Buy
30,815
+1,913
+7% +$194K 0.02% 631
2014
Q2
$2.76M Sell
28,902
-155
-0.5% -$13.9K 0.02% 711
2014
Q1
$2.64M Buy
29,057
+544
+2% +$52.9K 0.02% 704
2013
Q4
$2.52M Sell
28,513
-206
-0.7% -$17.2K 0.02% 708
2013
Q3
$2.27M Buy
28,719
+6,860
+31% +$539K 0.02% 716
2013
Q2
$1.5M Buy
+21,859
New +$1.52M 0.01% 880

Other funds holding BBH

LPL Financial's BBH Position: Q1 2026 in Review

LPL Financial reduced its VanEck Biotech ETF (BBH) stake by 17% in Q1 2026, selling an estimated $1.01M and leaving 26,551 shares worth $4.99M. The position accounts for ﹤0.01% of the portfolio, ranked #2625.

LPL Financial first reported a position in BBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.36M in Q4 2015. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • LPL Financial held 26,551 shares of VanEck Biotech ETF worth $4.99M as of Q1 2026.
  • LPL Financial sold 5,262 VanEck Biotech ETF shares in Q1 2026, an estimated $1.01M.
  • VanEck Biotech ETF made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #2625 holding.
  • LPL Financial first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 52 quarters since.
  • LPL Financial's VanEck Biotech ETF position peaked at $8.36M in Q4 2015.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.